OTC Pharmaceuticals - Finland

Finland

The OTC Pharmaceuticals market in Finland is projected to generate revenue of US$390.30m in 2024.
It is expected to experience an annual growth rate of 2.81% (CAGR 2024-2029).
Among the various markets in this market, Other OTC Pharmaceuticals holds the largest market share, with a volume of US$142.00m in 2024.
When compared globally, the in the United States leads in revenue generation, with an estimated revenue of US$41,240.00m in 2024.
In terms of per capita revenue, in Finland generates approximately US$70.33 per person in 2024.
As for online sales, it is anticipated that 17.53% of the total revenue in the OTC Pharmaceuticals market will come from online channels by 2024.
The demand for OTC pharmaceuticals in Finland is driven by a growing aging population seeking self-care solutions.

Key regions: United States, China, Germany, Japan, Europe

Definition:
The Over-the-Counter Pharmaceuticals market includes non-prescription medications, treatments, and healthcare products that are available directly to consumers without a prescription from a licensed healthcare professional. It includes both products which are exclusively sold in pharmacies and products which can be purchased elsewhere such as supermarkets, and online retailers. Sales by hospitals are not included.

Structure:
The market is subdivided into Analgesics, Cold and Cough Remedies, Digestives and Intestinal Remedies, Skin Treatment, Vitamins and Minerals, Hand Sanitizer, Eye care, Sleep aids, Wound care, and Other OTC Pharmaceuticals. The Analgesics market covers non-prescription pain-relief medications which help to relief aches, pains and fevers. Cold & Cough market covers non-prescription remedies aimed at relieving nasal congestion, coughing, sore throat, and related cold discomforts. The Digestives and Intestinal Remedies market encompasses non-prescription products designed to alleviate symptoms related to digestive discomfort and intestinal issues. The Skin Treatment market includes non-prescription medications formulated to address various dermatological concerns such as acne, eczema and dryness. The Vitamins and Minerals market comprises non-prescription dietary supplements containing essential nutrients such as vitamins and minerals. The Hand sanitizer market covers sanitizing products which are applied on hands to effectively reduce the presence of bacteria and viruses. The Eye Care market covers non-prescription products to address common eye-related discomforts such as dryness, irritation or redness. The Sleep Aids market covers non-prescription products designed to promote relaxation, alleviate insomnia, and improve sleep quality. The Wound Care market includes non-prescription products designed to facilitate wound healing and prevent infection.

Additional information:
OTC Pharmaceuticals comprises revenues, average revenue per capita. Sales channels show online and offline revenue. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

Market

Region

Region comparison

Currency

Analyst Opinion

The OTC Pharmaceuticals market in Finland is experiencing steady growth due to several factors. Customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors all contribute to the development of the OTC Pharmaceuticals market in Finland.Customer preferences play a significant role in shaping the OTC Pharmaceuticals market in Finland. Finnish consumers value convenience and accessibility, which has led to an increased demand for over-the-counter medications. The ease of purchasing OTC medications without a prescription aligns with the preferences of Finnish consumers who prioritize convenience and self-care.Trends in the market also contribute to the growth of the OTC Pharmaceuticals market in Finland. One notable trend is the increasing focus on preventive healthcare. Finnish consumers are becoming more proactive in managing their health and are seeking OTC medications to address minor ailments and prevent more serious health issues. This trend has resulted in a wider range of OTC medications being available in the market, catering to the specific needs of Finnish consumers.Local special circumstances in Finland further drive the development of the OTC Pharmaceuticals market. The Finnish healthcare system emphasizes self-care and encourages individuals to take responsibility for their health. This approach aligns with the availability and accessibility of OTC medications, making them an integral part of the Finnish healthcare landscape. Additionally, the high level of trust in the Finnish healthcare system and the quality of OTC medications contributes to their popularity among consumers.Underlying macroeconomic factors also play a role in the growth of the OTC Pharmaceuticals market in Finland. The country's stable economy and high standard of living enable consumers to afford OTC medications. The strong healthcare infrastructure and government support for self-care initiatives further contribute to the growth of the market. Additionally, Finland's aging population drives the demand for OTC medications as older individuals often require medications for chronic conditions or age-related ailments.In conclusion, the OTC Pharmaceuticals market in Finland is developing due to customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors. Finnish consumers value convenience and accessibility, leading to an increased demand for OTC medications. The trend towards preventive healthcare and the emphasis on self-care further contribute to the growth of the market. Local special circumstances, such as the Finnish healthcare system's focus on self-care, also play a role. Finally, the country's stable economy, high standard of living, and aging population all contribute to the development of the OTC Pharmaceuticals market in Finland.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.